Tupy S.A. (BVMF:TUPY3)

Checkpoint Therapeutics Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,713	2,376	1,593	1,510	1,272	1,425
Cash & Short-Term Investments	1,713	2,376	1,593	1,510	1,272	1,425
Cash Growth	-8.69%	49.16%	5.51%	18.66%	-10.71%	69.65%
Accounts Receivable	2,028	1,837	1,832	2,031	1,251	683.4
Other Receivables	442.81	533.08	424.43	329.16	323.22	226.44
Receivables	2,471	2,518	2,383	2,511	1,669	909.84
Inventory	2,434	2,492	2,199	2,208	1,488	937.63
Prepaid Expenses	-	-	-	18.19	12.46	-
Other Current Assets	204.64	73.83	10.87	179.81	142.38	57.24
Total Current Assets	6,823	7,460	6,187	6,427	4,584	3,330
Property, Plant & Equipment	2,817	2,941	2,793	2,584	2,133	1,727
Long-Term Investments	8.96	10.44	9.59	15.5	12.43	11.65
Goodwill	10.71	-	-	41.23	41.23	41.23
Other Intangible Assets	120.7	137.48	157.1	109.89	84.17	130.52
Long-Term Deferred Tax Assets	798.22	846.28	780.52	657.13	533.9	428.73
Other Long-Term Assets	114.53	115.55	358.17	408.54	122.43	444.52
Total Assets	10,693	11,511	10,285	10,243	7,511	6,113
Accounts Payable	1,575	1,483	1,376	1,682	1,240	616.19
Accrued Expenses	334.47	421.31	418.73	466.62	304.57	200.48
Short-Term Debt	-	-	-	-	-	329.52
Current Portion of Long-Term Debt	299.14	638.12	662.93	284.3	507.49	72.4
Current Income Taxes Payable	109.12	59.04	71.18	153.36	39.34	2.4
Current Unearned Revenue	-	316.65	248.26	194.99	125.82	169.69
Other Current Liabilities	615.92	473.19	469.92	608.63	176.06	123.37
Total Current Liabilities	2,933	3,391	3,247	3,390	2,393	1,514
Long-Term Debt	3,905	4,075	3,057	3,197	2,104	1,802
Long-Term Leases	53.63	56.73	70.43	38.59	-	21.35
Other Long-Term Liabilities	380.36	386.46	477.79	491.61	187.77	156.74
Total Liabilities	7,371	8,012	6,957	7,209	4,757	3,560
Common Stock	1,434	1,434	1,178	1,054	1,054	1,060
Retained Earnings	1,057	1,069	1,434	1,178	792.62	645.19
Treasury Stock	-195.68	-141.92	-3.61	-0.45	-0.01	-0.37
Comprehensive Income & Other	1,019	1,131	716.61	808.93	906.17	848.34
Total Common Equity	3,314	3,492	3,324	3,040	2,753	2,553
Minority Interest	7.72	7.77	3.59	-5.48	0.67	-
Shareholders' Equity	3,322	3,499	3,328	3,034	2,753	2,553
Total Liabilities & Equity	10,693	11,511	10,285	10,243	7,511	6,113
Total Debt	4,258	4,770	3,791	3,520	2,611	2,226
Net Cash (Debt)	-2,545	-2,394	-2,198	-2,010	-1,339	-800.43
Net Cash Per Share	-17.80	-16.46	-15.12	-13.85	-9.23	-5.56
Filing Date Shares Outstanding	135	136.47	143.99	144.16	144.18	144.15
Total Common Shares Outstanding	135	136.47	143.99	144.16	144.18	144.15
Working Capital	3,890	4,069	2,940	3,036	2,191	1,816
Book Value Per Share	24.55	25.59	23.09	21.09	19.09	17.71
Tangible Book Value	3,183	3,354	3,167	2,889	2,627	2,382
Tangible Book Value Per Share	23.57	24.58	22.00	20.04	18.22	16.52
Land	363.23	370.29	339.94	345.52	143.68	86.48
Buildings	1,716	1,768	1,508	1,503	1,488	979.89
Machinery	6,590	6,791	6,205	6,159	5,736	4,591
Construction In Progress	542.88	578.03	582.54	405.83	243.11	128.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.